We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+31.83%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$673M
AUM Growth
+$38.6M
(+6.1%)
Cap. Flow
-$75.1M
Cap. Flow
% of AUM
-11.17%
Top 10 Holdings %
Top 10 Hldgs %
7.9%
Holding
423
New
137
Increased
28
Reduced
113
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$4.45M |
| 2 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$4.44M |
| 3 |
Simply Good Foods
SMPL
|
+$4.4M |
| 4 |
Chefs' Warehouse
CHEF
|
+$4.1M |
| 5 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$3.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TBCH
Turtle Beach Corp
TBCH
|
+$6.67M |
| 2 |
CTLP
Cantaloupe
CTLP
|
+$5.28M |
| 3 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$5.04M |
| 4 |
Sunrun
RUN
|
+$4.76M |
| 5 |
ROCC
Ranger Oil Corporation Class A Common Stock
ROCC
|
+$4.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.02% |
| 2 | Technology | 20.75% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Industrials | 11.37% |
| 5 | Consumer Staples | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Fox Factory Holding Corp
FOXF
$785M
| $2.67M | 0.4% |
+38,082
| New | +$2.33M |
|
127
3D Systems Corp
DDD
$462M
| $2.63M | 0.39% |
+139,201
| New | +$2.4M |
|
128
MongoDB
MDB
$28.8B
| $2.6M | 0.39% |
31,936
-20,265
| -39% | -$1.35M |
|
129
Ollie's Bargain Outlet
OLLI
$4.51B
| $2.58M | 0.38% |
26,896
-2,048
| -7% | -$163K |
|
130
AppFolio
APPF
$6.79B
| $2.58M | 0.38% |
+32,890
| New | +$2.49M |
|
131
OrthoPediatrics
KIDS
$536M
| $2.5M | 0.37% |
68,217
+37,045
| +119% | +$1.13M |
|
132
Codexis
CDXS
$156M
| $2.49M | 0.37% |
145,099
-11,126
| -7% | -$180K |
|
133
Vishay Precision Group
VPG
$1.22B
| $2.43M | 0.36% |
65,088
+62
| +0.1% | +$2.52K |
|
134
CareDx
CDNA
$2.48B
| $2.43M | 0.36% |
84,110
-59,391
| -41% | -$1.11M |
|
|
NXGN
135
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.42M | 0.36% |
120,476
-53,183
| -31% | -$1.13M |
|
136
Sarepta Therapeutics
SRPT
$1.68B
| $2.38M | 0.35% |
14,766
-10,926
| -43% | -$1.49M |
|
137
Allient
ALNT
$1.53B
| $2.33M | 0.35% |
64,316
+96
| +0.1% | +$3.12K |
|
|
GTLS
138
DELISTED
Chart Industries
GTLS
| $2.33M | 0.35% |
29,739
-11,131
| -27% | -$824K |
|
|
LOXO
139
DELISTED
Loxo Oncology, Inc
LOXO
| $2.32M | 0.35% |
13,593
-3,310
| -20% | -$556K |
|
140
Usana Health Sciences
USNA
$422M
| $2.29M | 0.34% |
18,972
-5,260
| -22% | -$653K |
|
141
iRadimed
IRMD
$1.17B
| $2.27M | 0.34% |
61,207
+24,433
| +66% | +$659K |
|
|
AZPN
142
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.26M | 0.34% |
19,830
-11,750
| -37% | -$1.34M |
|
143
Encompass Health
EHC
$11.2B
| $2.23M | 0.33% |
36,013
-29,542
| -45% | -$1.8M |
|
|
AMED
144
DELISTED
Amedisys
AMED
| $2.23M | 0.33% |
17,836
-23,076
| -56% | -$2.55M |
|
145
Regenxbio
RGNX
$638M
| $2.2M | 0.33% |
29,195
-8,225
| -22% | -$593K |
|
|
AYX
146
DELISTED
Alteryx Inc
AYX
| $2.2M | 0.33% |
38,473
-24,090
| -39% | -$1.23M |
|
147
Medifast
MED
$108M
| $2.19M | 0.33% |
9,909
-9,820
| -50% | -$1.99M |
|
148
Apyx Medical
APYX
$176M
| $2.12M | 0.32% |
+299,040
| New | +$1.66M |
|
|
IMMU
149
DELISTED
Immunomedics Inc
IMMU
| $2.04M | 0.3% |
98,026
-49,374
| -33% | -$1.17M |
|
|
CDMO
150
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.02M | 0.3% |
+294,874
| New | +$1.75M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
ICCFIA
PLFA
EAM Investors's Q3 2018 Portfolio in Review
As of Q3 2018, EAM Investors held 423 positions worth $673M, up 6.1% from $634M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
EAM Investors withdrew a net $75.1M in Q3 2018, closing 126 positions and reducing 113 holdings. Its most notable exit was Turtle Beach Corp, an estimated $6.67M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $5.17M.
- EAM Investors's largest Q3 2018 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 63,177 shares worth $5.17M.
- EAM Investors added most to Artivion in Q3 2018, an estimated $2.7M increase.
- EAM Investors's biggest Q3 2018 reduction was PJT Partners, cutting an estimated $3.14M.
- EAM Investors fully exited Turtle Beach Corp in Q3 2018, selling an estimated $6.67M.
- EAM Investors's ten largest holdings make up 7.9% of its $673M portfolio in Q3 2018.
- EAM Investors opened 137 new positions and closed 126 in Q3 2018.
- EAM Investors's portfolio value rose 6.1% quarter-over-quarter to $673M.
Based on EAM Investors's 13F filing for Q3 2018, filed 8 Nov 2018.